Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Feb 11;18:17539447241230400. doi: 10.1177/17539447241230400

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2024

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 3. — Summary of diagnostic and therapeutic recommendations for vasospastic angina.

ACEi, angiotensin-converting enzyme inhibitor; ACh, acetylcholine; ARB, Angiotensin II receptor blocker; CAD, coronary artery disease; CCBs, calcium-channel blockers; CCTA, coronary computed tomography angiography; CMD, coronary microvascular dysfunction; IC, intracoronary; IOCA, ischaemia with obstructive coronary arteries; LANs, long-acting nitrates; LVEDP, left ventricle end diastolic pressures; RF, risk factor; VSA, vasospastic angina.